Unlock instant, AI-driven research and patent intelligence for your innovation.

Process for Preparation of Cyclic Prodrugs of PMEA and PMPA

a technology of cyclic prodrugs and cyclic esters, which is applied in the field of process, can solve the problems of poor oral bioavailability, poor cell penetration, limited tissue distribution, etc., and achieve the effects of reducing trans levels, reducing the solubility of free base dichloridate, and increasing lipophilicity

Inactive Publication Date: 2007-08-30
METABASIS THERAPEUTICS INC
View PDF38 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention is directed towards a process for making certain compounds with improved cis isomer content. The process involves enhancing the cis isomers through a coupling method, which involves adding a phosphonic acid and a chiral alcohol in the presence of a specific catalyst. The resulting compounds have a higher cis isomer content and enhanced d.e. The invention also describes a method for making substantially enantiomerically pure cis cyclic esters of PMEA and PMPO3H2, which involves adding an acid and crystallizing the salt form. The invention also provides methods for making the desired cis isomers and enhances their production through the use of a specific catalyst."

Problems solved by technology

Compounds containing phosphonic acids and their salts are highly charged at physiological pH and therefore frequently exhibit poor oral bioavailability, poor cell penetration and limited tissue distribution (e.g., CNS).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for Preparation of Cyclic Prodrugs of PMEA and PMPA
  • Process for Preparation of Cyclic Prodrugs of PMEA and PMPA
  • Process for Preparation of Cyclic Prodrugs of PMEA and PMPA

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of 3-(3-Chlorophenyl)-3-oxo-propanoic acid (1)

[0101] A 12 L, 3-neck round bottom flask was equipped with a mechanical stirrer and addition funnel (2 L). The flask was flushed with nitrogen and charged with diisopropylamine (636 mL) and THF (1.80 L). The stirred contents were cooled to −20° C. n-Butyllithium (1.81 L of a 2.5 M solution in hexanes) was added slowly with stirring, and the temperature was maintained between −20 and −28° C. After the addition was complete (30 min), the addition funnel was rinsed with hexanes (30 mL) and the stirred solution was then cooled to −62° C. Trimethylsilyl acetate (300 g) was added slowly with stirring, maintaining the temperature at 4, 70 g), filtered and concentrated under reduced pressure to give 827 g of a yellow solid. The crude solid was slurried in hexanes (2.2 L) and transferred to a round bottom flask equipped with a mechanical stirrer. The mixture was stirred at 1H-NMR analysis for this example and all following examples w...

example 2

Preparation of (S)-3-(3-Chlorophenyl)-3-hydroxypropanoic acid (2)

[0105]

[0106] A 12 L, 3-neck round bottom flask was equipped with a mechanical stirrer and addition funnel (1 L). The flask was flushed with nitrogen and charged with 3-(3-chlorophenyl)-3-oxo-propanoic acid (275.5 g) 1 and dichloromethane (2.2 L). A thermocouple probe was immersed in the reaction slurry and the stirred contents were cooled to −20° C. Triethylamine (211 mL) was added over 5 minutes to the stirred slurry and all solids dissolved. A dichloromethane solution of (−)-B-chlorodiisopinocampheylborane (1.60 M, 1.04 L) was charged to the addition funnel, and then added slowly with stirring while maintaining the temperature between −20 and −25° C. After the addition was complete (approximately 35 min), the solution was warmed to ice bath temperature (2-3° C.) and stirred. After approximately 4 hours of stirring an in-process NMR analysis indicated the starting material 1 was <4%.

[0107] The residual starting mate...

example 3

Preparation of (S)-(−)-1-(3-Chlorophenyl)-1,3-propanediol (3)

[0112] A 12 L, 3-neck round bottom flask was equipped with a mechanical stirrer, addition funnel (2 L) and thermometer. The flask was flushed with nitrogen and charged with (S)-3-(3-chlorophenyl)-3-hydroxypropanoic acid 2 (206.7 g) and THF (850 mL), and the stirred solution was cooled to 5° C. (ice bath). A 1 M borane in THF solution (2.14 L) was charged to the addition funnel, and then added slowly with stirring maintaining the temperature at 4, 322 g), filtered and concentrated under reduced pressure to provide 189.0 g of a pale yellow oil (101%). Preliminary analysis of the oil was by 1H-NMR (CDCl3).

[0113] The oil was purified by vacuum distillation and the fraction at 125-155° C. / 0.15 mmHg was collected.

[0114] Recovery=180.9 g

[0115] Colorless oil 3 (94.0%).

[0116]1H-NMR (CDCl3): δ=2.9-3.1 (m, 2H), 2.5 (bs, 2H), 3.9 (t, J=5 Hz, 2H), 4.9(dd, J=7.4, 4.8 Hz, 1H), 7.2-7.4 (m, 4H).

Procedure for ee Determination

[0117] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperaturesaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The method of preparing compounds of Formula I is described: wherein: M and V are cis to one another and MPO3H2 is a phosphonic acid selected from the group consisting of 9-(2-phosphonylmethoxyethyl)adenine, and (R)-9-(2-phosphonylmethoxypropyl)adenine; wherein V is phenyl, optionally substituted with 1-2 substituents selected from a group consisting of fluoro, chloro, and bromo; comprising: coupling a chiral 1-phenylpropane-1,3-diol, wherein the phenyl may be optionally substituted, with MPOCl2 or an N-6 substituted analogue thereof. Additionally, methods and salt forms are described that enable isolation and purification of the desired isomer.

Description

FIELD OF INVENTION [0001] The present invention is directed towards a process of synthesis of substituted six-membered cyclic 1-aryl-1,3-propanyl esters of PMEA and PMPA. More specifically, the invention relates to the process of synthesis of halogen substituted cyclic-1-phenyl-1,3-propanyl esters of PMEA and PMPA that have cis stereochemistry. BACKGROUND OF THE INVENTION [0002] The following description of the background of the invention is provided to aid in understanding the invention, but is not admitted to be, or to describe, prior art to the invention. All publications are incorporated by reference in their entirety. [0003] 9-(2-phosphonylmethoxyethyl)adenine (PMEA), (R)-9-(2-phosphonyl-methoxypropyl)adenine (PMPA) and related analogues (U.S. Pat. No. 4,808,716; U.S. Pat. No. 5,142,051) are phosphonic acids that exhibit antiviral activity, including activity against hepatitis B and HIV (De Clercq et al., Antiviral Res. 8: 261-7(1987); Balzarini et al., Biochem Biophys. Res. Co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07F9/655C07D263/04A61K31/66A61P31/12A61P31/18A61P35/00C07F9/6571C07F9/6574
CPCC07F9/657181A61P31/12A61P31/18A61P35/00Y02P20/55
Inventor KOPCHO, JOSEPH J.REDDY, K. RAJAMATELICH, MICHAEL C.UGARKAR, BHEEMARAO G.
Owner METABASIS THERAPEUTICS INC